United Capital Financial Advisors LLC Boosts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

United Capital Financial Advisors LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,746 shares of the healthcare conglomerate's stock after acquiring an additional 447 shares during the period. United Capital Financial Advisors LLC's holdings in UnitedHealth Group were worth $37,305,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also made changes to their positions in the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $25,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $28,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $30,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group in the fourth quarter valued at about $30,000. Finally, Promus Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at approximately $32,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 22.0 %

Shares of NYSE:UNH traded down $128.94 on Friday, hitting $456.10. The company had a trading volume of 29,048,929 shares, compared to its average volume of 4,373,443. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $438.50 and a 1 year high of $630.73. The firm's 50-day simple moving average is $512.95 and its two-hundred day simple moving average is $540.65. The firm has a market capitalization of $417.20 billion, a price-to-earnings ratio of 29.43, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the firm earned $6.91 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.84%. UnitedHealth Group's dividend payout ratio is currently 54.19%.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on UNH. Barclays dropped their price target on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Mizuho lifted their price target on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Cantor Fitzgerald reissued an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, KeyCorp reaffirmed an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Twenty-one analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $632.85.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.